Adverum Biotechnologies Inc reports results for the quarter ended in March - Earnings Summary

Adverum Biotechnologies

16/05/2022 13:00

* Adverum Biotechnologies Inc  ADVM.OQ  reported a quarterly
adjusted loss of 38 cents​​ per share for the quarter ended in
March. The mean expectation of four analysts for the quarter was
for a loss of 31 cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * Adverum Biotechnologies Inc's reported EPS for the quarter
was a
loss of 38 cents​.
    * The mean earnings estimate of analysts had risen by
about 7.9%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Adverum Biotechnologies Inc shares had fallen by 36.2%
this
quarter and lost 52.5% so far this year.
    * The company reported a quarterly loss of $37.91 million.
    * Wall Street's median 12-month price target for Adverum
Biotechnologies Inc is $4.00 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 16 at 12:00 p.m.  ​All
figures in US dollars unless otherwise stated